Talk:Amitriptyline: Difference between revisions
>Malikertens read it |
>Tracer m Tracer moved page Amitriptyline to Talk:Amitriptyline: Moved to talk page |
||
(2 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
<!-- kenan's mum is fat --> | |||
{{SubstanceBox/Amitriptyline}}'''Amitriptyline''' (trade name '''Elavil''' or '''Vanatrip''') is a [[Antidepressants#Tricyclics|tricyclic antidepressant]] drug used to treat depression, chronic neuropathic pain and migraines. It was the second known antidepressant and developed by the American pharmaceutical company [https://en.wikipedia.org/wiki/Merck_%26_Co. Merck] in the late 1950s. Amitriptyline is on the WHO Model List of Essential Medicines, the most important medications needed in a basic health system. Due to the frequency and prominence of side effects, amitriptyline is generally considered a second-line medication. | |||
It is also rarely abused at strong and high doses for euphoric and sedative effects, though there is almost no information about its effects as a recreational drug | |||
==History and culture== | |||
In the 1950s the pharmaceutical company [https://en.wikipedia.org/wiki/Merck_%26_Co. Merck] proposed clinical trials to use amitriptyline as a treatment for schizophrenia, researcher Frank Ayd instead suggested that the medication be used as an antidepressant. Ayd treated 130 patients with amitriptyline and reported that it had similar qualities to [[imipramine]], the first and only tricyclic antidepressant. It was approved for treatment of depression by the FDA in 1961. | |||
Pharmaceutical companies [https://en.wikipedia.org/wiki/Hoffmann-La_Roche Roche] and [https://en.wikipedia.org/wiki/Lundbeck Lundbeck] were also able to create patents on the drug thanks to a quirk of the patent law in the EU at the time allowing patents only on the chemical synthesis, but not on the drug itself. | |||
Effects: | The drug quickly surpassed its predecessor, [[imipramine]], because of its stronger anxiolytic effect and a campaign by the Merck company, raising awareness of depression as a clinical issue. Between 1998 and 2017 amitriptyline was the most prescribed antidepressant for 11-17 year olds in England | ||
==Chemistry== | |||
<br /> | |||
==Pharmacology== | |||
<br /> | |||
==Subjective Effects== | |||
{{Preamble/SubjectiveEffects}} | |||
==Toxicity and harm potential== | |||
<br /> | |||
==See also== | |||
<br /> | |||
==External links== | |||
*[https://en.wikipedia.org/wiki/Amitriptyline Amitriptyline (Wikipedia)] | |||
*[https://www.drugbank.ca/drugs/DB00321 Amitriptyline (DrugBank)] | |||
<br /> |